Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Gynecological topics in practice

From menstrual cramps to medications in pregnancy

    • Congress Reports
    • Endocrinology and Diabetology
    • Gynecology
    • RX
  • 3 minute read

The annual symposium for general practitioners and gynecologists was held in Olten at the end of January. HAUSARZT PRAXIS was on site and reports on the one hand about the problem of medication during pregnancy, and on the other hand about primary and secondary dysmenorrhea.

Prof. Dr. med. Irene Hösli from the Clinic for Obstetrics and Pregnancy Medicine in Basel spoke on the topic of “Medications in Pregnancy”. She noted that medication use in pregnant women in the first three months has increased by 60% over the past 30 years. This is mainly due to the increase in maternal chronic diseases with increasing age, increase in BMI, etc. Pregnant women today take up to four different medications during the first trimester, and even up to eight medications during the entire pregnancy, often in self-medication. Malformations occur in 3-6% of all pregnancies, and drugs are the trigger in about 1-5% of cases (Table 1).

Pharmacological substances therefore always involve potential risks for the mother and the unborn child, which must be weighed up depending on the situation. This does not apply to folic acid and vitamin preparations administered as dietary supplements before and during pregnancy to provide optimal support for mother and child.
Prof. Hösli specifically addressed the problem of depression in pregnancy: According to recent data, 3-6% of all pregnant women are treated with SSRIs due to moderate or severe depression. Pregnant women with known depression should definitely continue antidepressant therapy because the relapse rate is very high, she said. The benefit would clearly outweigh the risk here. Taken periconceptually or in the first trimester, there was no increased risk of malformation for either sertraline or citralopram, and a slightly increased risk of cardiac malformation for fluoxetine and paroxetine. Among the tricyclic antidepressants, nortriptyline, lmipramine and amitriptyline are the drugs of choice. In the second trimester or peripartum, adaptation disorders may occur in two to three out of ten newborns on antidepressants, so neonatal monitoring may be necessary. Whether medication should be reduced or discontinued two to four weeks before birth is controversial.

Management of dymenorrhea

Prof. Dr. med. Wolfgang Schöll from the University Clinic for Gynecology at the Inselspital in Bern provided information on the treatment of primary and secondary dysmenorrhea. Primary dysmenorrhea affects the majority of all young girls and women, 60-70%: During menstruation, recurrent, cramp-like lower abdominal pain occurs without any recognizable pathological anatomy. Nausea, vomiting, headache, backache, lightheadedness, and even diarrhea can accompany the cramping abdominal pain that begins hours before menstruation and can last for days.

However, especially in the third and fourth decades of life, progressive secondary dysmenorrhea may then occur with a painful condition during menstruation associated with a pathologically palpable finding in the pelvis, often endometriosis. Müller’s malformations, adenomyosis, fibroids, ovarian cysts, endometrial polyps, adhesions, cervical canal stenosis, recumbent IUDs, genital varicosis, and nongenital changes may be other causes of secondary dysmenorrhea.

The severity of the menstrual pain and the possible obstruction of daily activities defines the use of analgesics. Non-steroidal anti-inflammatory drugs (NSAIDs) are the first choice, according to Prof. Schöll, with COX-1 inhibitors preferred over COX-2 inhibitors. In particularly severe cases, therapy can begin the day before the expected menstrual period. Mefenamic acid derivatives may be slightly more effective than propionic acid derivatives such as lbuprofen or naproxen, if appropriate. Metamizole, which is not an NSAID and has excellent efficacy for visceral pain, is a good alternative. The use of non-drug approaches such as acupuncture and transcutaneous electrical nerve stimulation (TENS) is also justified by the evidence, according to Prof. Schöll. If NSAIDs result in inadequate pain control or if anticonception is desired, oral contraceptive pills (OCPs) are used to lower uterine prostaglandin levels and reduce the amount of menstrual blood by suppressing ovulation. ln severe cases, NSAIDs and OCPs may be combined. In secondary dysmenorrhea, which requires further pathological clarification, causal multimodal therapy is necessary.

Séverine Bonini

Source: 32nd Symposium for General Practitioners and Gynecologists, January 30, 2014, Olten.

HAUSARZT PRAXIS 2014; 9(3): 34-35

Publikation
  • HAUSARZT PRAXIS
Related Topics
  • Acupuncture
  • Analgesics
  • cardiac malformation
  • COX-1
  • COX-2 inhibitors
  • Depression
  • Dymenorrhea
  • Folic acid
  • Gynacology
  • Menstruation
  • Nausea
  • NSAID
  • OCP
  • oral contraceptive pill
  • Vitamin
Previous Article
  • Lung, kidney cancer and chronic myeloid leukemia

What does modern clinical practice look like?

  • Congress Reports
  • Oncology
  • RX
View Post
Next Article
  • Palliation

Giving more life to the days

  • Education
  • Oncology
  • Prevention and health care
  • Psychiatry and psychotherapy
  • RX
View Post
You May Also Like
View Post
  • 8 min
  • Psoriasis and PsA

Biologics, oral peptide and trivalent nanobody – current results and trends

    • Allergology and clinical immunology
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • RX
    • Studies
View Post
  • 5 min
  • Cancer in Europe: facts and analysis

New Health Policy Report published

    • General Internal Medicine
    • Oncology
    • Practice Management
    • Prevention and health care
    • RX
    • Studies
View Post
  • 4 min
  • Gastrointestinal complaints

PPI regulation under the microscope

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Pharmacology and toxicology
    • RX
    • Studies
View Post
  • 2 min
  • Chronic pain

Nano-ECS modulator Adezunap improves therapy success

    • Congress Reports
    • General Internal Medicine
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Rheumatology
    • RX
    • Studies
View Post
  • 6 min
  • Wound management: clinical diagnostics

Assessing the risk of infection – from the ABCDE to the TILI score

    • Congress Reports
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Geriatrics
    • Infectiology
    • Interviews
    • Physical medicine and rehabilitation
    • Prevention and health care
    • RX
View Post
  • 4 min
  • Study report

Digital patient education for atrial fibrillation shows measurable effects

    • Cardiology
    • Education
    • General Internal Medicine
    • RX
    • Studies
View Post
  • 4 min
  • New practice guideline for fibromyalgia syndrome

Good times, bad times

    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Pharmacology and toxicology
    • Physical medicine and rehabilitation
    • Rheumatology
    • RX
    • Sports Medicine
    • Studies
View Post
  • 16 min
  • IBDmatters - Synergy effects for IBD pathways

How combination therapies lead to better treatment results

    • CME continuing education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Genetics
    • RX
    • Studies
    • Training with partner
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
Top CME content
  • 1
    How combination therapies lead to better treatment results
  • 2
    Interplay between cancer and mental illness
  • 3
    PH and lung diseases
  • 4
    Treatment of comorbidities in older people
  • 5
    Multidisciplinary teams in oncology

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.